The newly cleared system is designed to perform both nearby fluoroscopy and digital X-rays to support more efficient room utilization and improve workflows, the Amsterdam-based company said.
Philips said that the ProxiDiagnost N90 is designed to provide enhanced, high-quality images using premium flat detector technology, improved support for staff workflow, increased patient accessibility and increased dose rate reduction for pediatric examinations.
“As a dual-use system, ProxiDiagnost N90 meets key dimensions of healthcare’s Quadruple Aim and is a smart choice for healthcare organizations that need a new fluoroscopy solution – particularly those in the U.S. that follow a nearby use method. We are setting the bar higher and enabling a confident diagnosis from the first frame. ProxiDiagnost N90 gives radiologists and technologists the ability to capture high-quality still or video images in a way that aligns with their workflow and provides an improved patient experience,” Philips diagnostic X-ray global marketing senior director Sandra Burghardt said in prepared remarks.
Earlier this month, Philips said it was continuing to divest itself of its legacy lighting business, selling off approximately $641.8 million (EUR €520.7 million) in shares of Philips Lighting.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.